Octagon Capital Advisors LP Ocular Therapeutix, Inc Transaction History
Octagon Capital Advisors LP
- $449 Million
- Q4 2024
A detailed history of Octagon Capital Advisors LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Octagon Capital Advisors LP holds 2,425,000 shares of OCUL stock, worth $18.2 Million. This represents 4.62% of its overall portfolio holdings.
Number of Shares
2,425,000
Previous 2,425,000
-0.0%
Holding current value
$18.2 Million
Previous $21.1 Million
1.84%
% of portfolio
4.62%
Previous 5.1%
Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
190Shares Held
132MCall Options Held
374KPut Options Held
179K-
Summer Road LLC West Palm Beach, FL13.9MShares$104 Million98.85% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.8MShares$96.4 Million4.83% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$95.8 Million17.98% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$86.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.48MShares$63.7 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $578M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...